通道突变以及对心力衰竭和心房动的易感性
Timothy M Olson1, Virginia V Michels, Jeffrey D Ballew
1Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA. olson.timothy@mayo.edu
JAMA
|January 27, 2005
概括
在SCN5A的遗传缺陷与扩张性心肌病 (DCM) 和心房动有关. 这些突变可以在家庭中引起早期心力衰竭和节律障碍.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
背景情况:
- 扩张性心肌病 (DCM) 是一种复杂的遗传性心脏疾病.
- 虽然许多DCM基因影响结构蛋白,但涉及离子通道的新机制正在出现.
- 对于DCM的完整遗传情景,人们的理解尚不完全.
研究的目的:
- 在已知的位置确定一个新的DCM基因.
- 在DCM患者队列中描述SCN5A突变.
- 在携带突变的亲属中评估DCM的患病率.
主要方法:
- 在一个家族的染色体3p上精确地绘制了DCM位点.
- 选156个DCM探针对候选基因的突变进行了选.
- 通过心声学,心电图和DNA分析评估亲属.
主要成果:
- 编码心脏通道的SCN5A被确定为候选基因.
- 发现了几种SCN5A突变 (误解和截断),与DCM分离,心房动和导电缺陷.
- 具有SCN5A突变的个体表现出可变的表达性,包括早期出现的DCM和心房动.
结论:
- 可遗传的SCN5A突变使个体易患早期DCM和心房动.
- SCN5A缺陷可以表现为心力衰竭,心律失常或两者兼而有之.
- 这突显了通道功能障碍在DCM病变发生过程中的作用.
相关概念视频
Heart Failure II: Pathophysiology
658
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
658
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.7K
Voltage-gated Ion Channels
10.2K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
10.2K
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K
Heart Failure Drugs: Diuretics
763
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
763


